Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012
Live Webcast to Begin at 6:30 a.m. EST
(firmenpresse) - DEERFIELD, IL -- (Marketwire) -- 10/29/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that it will host a live webcast to discuss the approval and initial launch of RAYOS® on Monday, November 12, 2012 at 6:30 a.m. Eastern Time. The webcast will be hosted by Timothy P. Walbert, chairman, president and chief executive officer of Horizon Pharma and will feature presentations from leading rheumatologists Maurizio Cutolo, M.D., of the University of Genova, Frank Buttgereit, M.D., of the Charité at the University of Berlin, and Arthur Weaver, M.D., of the University of Nebraska. The live webcast and a replay may be accessed by visiting Horizon's website at .
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit .
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.10.2012 - 11:30 Uhr
Sprache: Deutsch
News-ID 197039
Anzahl Zeichen: 0
contact information:
Town:
DEERFIELD, IL
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 212 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
